2013 Lung Cancer Research Foundation Annual Grant Program
Heidi Greulich, PhD
Dana-Farber Cancer Institute
Research Project:
Leveraging ERBB2 mutations for lung cancer treatment
Summary:
Dr. Greulich’s research identifies inhibitor combinations that effectively inhibit survival of tumor cell lines harboring ERBB2 mutations.